Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced a corporate restructuring to ...
Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been approved by the Danish ...
This article summarizes the most significant insider buying and selling activities reported on Friday for US-listed companies ...
February 14, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and ...
Roche Holding AG Akt 1.04% CHF232.83B ...
Roche Holding AG Akt 2.44% CHF235.6B ...
After hours: February 13 at 4:09:41 PM EST Loading Chart for ACHL ...
After hours: 7:47:54 p.m. EST ...
I would like to welcome you to Canopy Growth's third-quarter fiscal 2025 financial results conference call. Currently, all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback